According to reports from Brussels media on January 15th, the World Vapers' Alliance (WVA) has recently released the latest results of the public consultation on the European Union Tobacco Products Directive (TPD). These results indicate a significant consensus among citizens, non-governmental organizations, and scientific institutions regarding the effectiveness of harm reduction products for smokers who wish to quit smoking.
According to public consultation data, 77% of respondents believe that harm reduction products are effective in helping smokers quit, with only 9% of EU citizens expressing opposition. Furthermore, as many as 82% of respondents disapprove the notion that new nicotine alternatives pose a risk to public health, with only 6% perceiving them as a threat.
Michael Landl, Director of the World Vapers' Alliance (WVA), expressed his concerns regarding the European Commission's current stance on harm reduction, stating that it not only lags behind but also blatantly disregards the perspective of consumers and scientific evidence. He emphasized the need for the Commission to acknowledge the fact that harm reduction products are not enemies, but rather crucial allies in the fight against smoking.
The successful harm reduction experiences in countries such as Sweden have become exemplars, highlighting the remarkable achievements of consumer-friendly harm reduction methods in reducing smoking rates. However, the European Commission's hostilities towards these approaches have been perplexing and have even had a negative impact on public health efforts.
Randall further pointed out: "Sweden's success story confirms the achievements that sensible harm reduction policies can bring. It is bewildering and even irresponsible that the European Commission continues to oppose these lifesaving products. The Commission should align its policies with clear evidence and public opinion, instead of clinging to outdated and ineffective approaches."
WVA urges the European Commission to reconsider its position and adopt a more evidence-based harm reduction approach, especially in the context of the upcoming Tobacco Products Directive (TPD) update. The recent consultation results should serve as a warning, emphasizing the urgency for policies that genuinely reflect public health and the needs of EU citizens.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
